Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment.
about
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsPrognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survivalDetection of minimal residual disease in pediatric acute lymphoblastic leukemia.Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters.DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia.Flow cytometric analysis of CD64 expression pattern and density in the diagnosis of acute promyelocytic leukemia: a multi-center study in Shanghai, China.Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
P2860
Q24604720-02BF5952-220C-40B6-B370-BF3CA2E28562Q35976588-0DD63EBB-1018-456C-8E3F-9C9F1DA8D583Q36781786-4DBB27CF-132C-4986-9BA4-0A20D3C41783Q38113738-FCF26158-A49D-410A-B3D0-133C40D07813Q38438814-471E56B9-3A1F-4710-9AB6-C9755B84BEABQ38802404-46727D97-E6CE-49F9-8DEB-5E1303746D10Q39958090-04444B34-6400-4F8D-81BD-0E9EB493179AQ43258471-D7D773A4-B7D4-4DD1-AC69-82FA0DE6EEA1Q44721604-BF975429-FCA5-49E0-95A0-59A97352EFB2Q54391883-A0335CFC-29E2-44E2-A2C6-4FCBEDB7F0CF
P2860
Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quality control of flow cytome ...... mia patients during treatment.
@ast
Quality control of flow cytome ...... mia patients during treatment.
@en
type
label
Quality control of flow cytome ...... mia patients during treatment.
@ast
Quality control of flow cytome ...... mia patients during treatment.
@en
prefLabel
Quality control of flow cytome ...... mia patients during treatment.
@ast
Quality control of flow cytome ...... mia patients during treatment.
@en
P2093
P921
P1476
Quality control of flow cytome ...... mia patients during treatment.
@en
P2093
Anna Porwit
Asa Jeppsson Ahlberg
Eeva-Riitta Savolainen
Elisabet Björklund
Erik Forestier
Goran Kauric
Hanne Marquart
Irma Matinlauri
Joanna Mazur
Kerstin Torikka
P304
P356
10.1097/MPH.0B013E3181A1C0E8
P50
P577
2009-06-01T00:00:00Z